These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Membrane-initiated estradiol signaling of epithelial-mesenchymal transition-associated mechanisms through regulation of tight junctions in human breast cancer cells. Jiménez-Salazar JE, Posadas-Rodríguez P, Lazzarini-Lechuga RC, Luna-López A, Zentella-Dehesa A, Gómez-Quiroz LE, Königsberg M, Domínguez-Gómez G, Damián-Matsumura P. Horm Cancer; 2014 Jun; 5(3):161-73. PubMed ID: 24771004 [Abstract] [Full Text] [Related]
43. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Cotrim CZ, Fabris V, Doria ML, Lindberg K, Gustafsson JÅ, Amado F, Lanari C, Helguero LA. Oncogene; 2013 May 09; 32(19):2390-402. PubMed ID: 22751110 [Abstract] [Full Text] [Related]
44. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line. Gottfried-Blackmore A, Croft G, McEwen BS, Bulloch K. Brain Res; 2007 Dec 09; 1186():41-7. PubMed ID: 18021758 [Abstract] [Full Text] [Related]
45. GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition. Kim Y, Lee D, Jo H, Go C, Yang J, Kang D, Kang JS. Aging (Albany NY); 2021 Feb 04; 13(3):3202-3217. PubMed ID: 33539321 [Abstract] [Full Text] [Related]
49. Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells. Fontana F, Raimondi M, Marzagalli M, Sommariva M, Limonta P, Gagliano N. Cells; 2019 Feb 11; 8(2):. PubMed ID: 30754655 [Abstract] [Full Text] [Related]
51. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells. Kallio A, Guo T, Lamminen E, Seppänen J, Kangas L, Väänänen HK, Härkönen P. Mol Cell Endocrinol; 2008 Jul 16; 289(1-2):38-48. PubMed ID: 18455292 [Abstract] [Full Text] [Related]
55. Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia. Gangkak G, Bhattar R, Mittal A, Yadav SS, Tomar V, Yadav A, Mehta J. Investig Clin Urol; 2017 Mar 16; 58(2):117-126. PubMed ID: 28261681 [Abstract] [Full Text] [Related]
56. 3,3'-Diindolylmethane Suppressed Cyprodinil-Induced Epithelial-Mesenchymal Transition and Metastatic-Related Behaviors of Human Endometrial Ishikawa Cells via an Estrogen Receptor-Dependent Pathway. Kim BG, Kim JW, Kim SM, Go RE, Hwang KA, Choi KC. Int J Mol Sci; 2018 Jan 08; 19(1):. PubMed ID: 29316692 [Abstract] [Full Text] [Related]
57. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway. Kim HJ, Jin BR, An HJ. Biomed Pharmacother; 2023 Apr 08; 160():114389. PubMed ID: 36791565 [Abstract] [Full Text] [Related]
59. Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2. Wu Q, Zhou Y, Chen L, Shi J, Wang CY, Miao L, Klocker H, Park I, Lee C, Zhang J. J Endocrinol; 2007 Oct 08; 195(1):89-94. PubMed ID: 17911400 [Abstract] [Full Text] [Related]